Listen to the Experts Discuss the Emerging benefits from Cardiovascular Renal Metabolic aspects of empagliflozin and linagliptin .

Rationality of combination of SGLT2i and DPP-4i | Dr. Rakesh Arora & Dr. Rohan Gupta

Listen to Endocrinologist and Diabetologist discuss the benefits of Empagliflozin &amp; Linagliptin usage in T2D management. This discussion will help clinicians to make informed decisions regarding the management of T2D using novel therapy of Empagliflozin &amp; Linagliptin.